Voya Investment Management LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 124.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 350,737 shares of the company's stock after acquiring an additional 194,290 shares during the period. Voya Investment Management LLC owned about 0.08% of GE HealthCare Technologies worth $27,421,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. CoreFirst Bank & Trust purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at $25,000. Runnymede Capital Advisors Inc. purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at $28,000. Bank of Jackson Hole Trust purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at $32,000. Flagship Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at $34,000. Finally, OFI Invest Asset Management purchased a new stake in GE HealthCare Technologies in the fourth quarter valued at $34,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
GEHC has been the subject of a number of research reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and boosted their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the company a "buy" rating in a report on Monday, April 14th. The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $96.50.
Get Our Latest Report on GEHC
GE HealthCare Technologies Stock Performance
Shares of GE HealthCare Technologies stock traded up $0.02 on Tuesday, reaching $68.09. 5,687,469 shares of the stock were exchanged, compared to its average volume of 3,272,290. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The business has a fifty day moving average price of $75.62 and a two-hundred day moving average price of $81.81. The firm has a market capitalization of $31.17 billion, a PE ratio of 15.73, a PEG ratio of 3.19 and a beta of 1.14.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.21%. GE HealthCare Technologies's payout ratio is 3.23%.
About GE HealthCare Technologies
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Recommended Stories

Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.